Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

Alessandra Raimondi, Federico Nichetti, Arndt Stahler, Harpreet Wasan, Enrique Aranda, Giovanni Randon, Annika Kurreck, Angela Meade, Eduardo Díaz‐Rubio, Monica Niger, Sebastian Stintzing, Federica Palermo, Tanja Trarbach, Michele Prisciandaro, Greta Sommerhäuser, David J. Fisher, Federica Morano, Filippo Pietrantonio, Dominik Paul Modest